Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I trial of TC 5619 in healthy volunteers.

Trial Profile

Phase I trial of TC 5619 in healthy volunteers.

Phase of Trial: Phase I

Latest Information Update: 08 May 2008

At a glance

  • Drugs Bradanicline (Primary)
  • Indications Cognition disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 08 May 2008 Status changed to completed by May 2008, according to a Targacept media release.
    • 08 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top